(Q51808078)

English

Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

excessive tearing

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Benjamin L. Miller

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

2

object named as

Michael Gilboa

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

author name string

Medy Tsalic

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

Bela Visel

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

Nissim Haim

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

publication date

1 January 2006

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Medical Oncology

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

23

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

57-61

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

https://scigraph.springernature.com/pub.10.1385/mo:23:1:57

0 references

Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel secretion in tears: association with lacrimal drainage obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel administered on a weekly basis for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16645230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:23:1:57

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16645230

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51808078&oldid=1993650891"